Donna Hanrahan Gambaccini (@EthicalLens) header
Donna Hanrahan Gambaccini (@EthicalLens) profile picture

Life Sciences Attorney exploring the healthcare, technology, business, bioethics, pharma, device & FDA regulatory landscape. Tweets≠legal advice, RT≠endorsement

New York, NY
Joined July 2010
Donna Hanrahan Gambaccini retweeted
Keeping light at end of #valuebasedcare tunnel in mind can help with pain of implementation. Whether means right yet or not, better #patient care is goal. https://teapawt.org/t.co/d0oTQR09Eb
2
3
#FDA issues “leap-frog” guidance on #3Dprinting of #medical product to bridge where we are today with #innovations of tomorrow fda.gov/downloads/MedicalDev… #pharma #meddevice
1
1
Donna Hanrahan Gambaccini retweeted
Many reasons & thoughts why #healthcare #CyberSecurity lags. Time to "Just Do It" as Nike says. https://teapawt.org/t.co/smKiF85m9n #IoMTchat #HIPAA
1
6
1
5
Donna Hanrahan Gambaccini retweeted
74% of meds in dev have potential to be first of kind – new ways of treating disease. More in new report: onphr.ma/2uEJrBI #GoBoldly
92
194
39
1,043
Happy to collaborate w/ Tara D'Orsi & Jim Shehan to share insight on the #CuresAct's impact on #drug & #device dev. https://teapawt.org/t.co/by93hCW5fx
Donna Hanrahan Gambaccini retweeted
In @Westlaw #pharma, attys @jimmyshehan Tara D'Orsi & @EthicalLens review changes made by the 21st Century Cures Act https://teapawt.org/t.co/srLhclLWhO
1
2
Donna Hanrahan Gambaccini retweeted
Medical device enforcement is getting more serious—particularly in Northeast ift.tt/2miVH2s #meddevice
2
2
Sparking Discussion & Fueling the Fire-#FDA Discussion Paper on LDTs https://teapawt.org/t.co/wF36oe6ggG #pharma #healthlaw #biotech #dna @LowensteinLLP
1
3
1
I'm in! Looking forward to it @jmorelnyc ! Life Science Industry: 2016 and 2017 in Review Webinar 2/16 2PM EST ow.ly/VnEi308OwaN teapawt.org/BerkleyLifeSci/status/…
Register @BerkleyLifeSci @BowmandBrooke webinar "Life Science Industry: 2016 and 2017 in Review" Feb 16 2PM (EST) ow.ly/VnEi308OwaN
1
#Diversity is a fact; #Inclusion is a choice-Celebrating Diversity in Compliance @SetonHallLaw w/ @JNJCares @PorzioLS @AstraZeneca @PSEGNews
2
2
Combating Resistance: Fed Efforts to Curb Misuse & Incentivize Development of #Antibiotic Drugs https://teapawt.org/t.co/kas6wq6F3m #publichealth #law
With a Whisper, Not a Shout, #FDA Breaks Silence on #Medical Product #Communications https://teapawt.org/t.co/FZruOdlwqY #pharma #marketing #rx #device
With a Whisper, Not a Shout, #FDA Breaks Silence on Medical Product Communications https://teapawt.org/t.co/FZruOdlwqY #pharma #meddevice #marketing
#FDA released draft guidance on Medical Product Communications Consistent w/ FDA-Required Labeling protect-us.mimecast.com/s/Zp… #offlabel #pharma
#FDA issues draft guidance on #Drug and #Device Manufacturer Communications w/ Payors, Formulary Committees, etc. protect-us.mimecast.com/s/LL…
1
1
Repeal of the #ACA just moved a step closer to reality - House passes budget resolution. #healthlaw teapawt.org/TheAtlantic/status/820…
Repeal of the Affordable Care Act just moved a step closer to reality theatln.tc/2j95OGF
1
1